Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2008 Aug 26;2:132–136. doi: 10.2174/1874364100802010132

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Shinoda et al.; Licensee Bentham Open.

This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

PMC Copyright notice

Fig. (2) — Changes in visual function after the microcurrent therapy at 4 weeks. Top: The averaged Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity score significantly improved from 29.5±5.1 to 31.8±5.0 (mean±SE, P=0.0407) in wet-type age-related macular degeneration (ARMD) patients and in dry-type ARMD patients (from 39.8±4.7 to 42.9±4.9, P=0.0401). Bottom: The averaged mean deviation of the automated perimetry improved from - 13.3±3.1 dB to -12.4±3.1 dB after treatment (mean±SE, P=0.0247) in wet-type ARMD patients while in dry-type ARMD patients, it changed from -9.3±3.2 dB to -9.3±2.8 dB (P>0.05). The ‘N.S.’ indicates ‘not significant’.